Stada Arzneimittel APAC

Stada Arzneimittel APAC is owned by Stada Arzneimittel. Stada Arzneimittel has a direct presence in 4 countries.

Stada Arzneimittel has 3 subsidiaries including Clonmel Healthcare, Hemofarm and Stada Arzneimittel APAC.

View the org chart displaying its 7 main executives

Most searched biographies at Stada Arzneimittel APAC

• Philippe Malecki, Deputy General Director, Vietnam
• Simon Yung, Director, Portfolio, Commercial Strategy & Emerging Ma...
• Sharmaine Abarientos, Country Manager, Philippines

Create your alert
to follow the executive moves at Stada Arzneimittel APAC.

Stada Arzneimittel has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Lucia Aleotti - Director at Menarini Group

Learn more about the Pharmaceuticals industry >

Press releases by Stada Arzneimittel APAC

Social media about Stada Arzneimittel APAC

• Stada Arzneimittel APAC on Wikipedia, Google News & Yahoo Finance
• Stada Arzneimittel APAC on LinkedIn, Twitter & YouTube

Contact by email its executives including Sharmaine Abarientos

Call Stada Arzneimittel APAC at +86 852 ...

View the org chart

Register to receive your alert

Report an error